20,088 Shares in Amrize Ltd $AMRZ Acquired by Hunter Perkins Capital Management LLC

Hunter Perkins Capital Management LLC bought a new position in Amrize Ltd (NYSE:AMRZ) in the third quarter, Holdings Channel reports. The institutional investor bought 20,088 shares of the company’s stock, valued at approximately $975,000.

Several other institutional investors and hedge funds have also recently modified their holdings of AMRZ. Kirr Marbach & Co. LLC IN increased its position in Amrize by 16.2% during the third quarter. Kirr Marbach & Co. LLC IN now owns 86,196 shares of the company’s stock worth $4,183,000 after purchasing an additional 12,022 shares during the last quarter. CHICAGO TRUST Co NA purchased a new stake in shares of Amrize during the 3rd quarter valued at approximately $218,000. Benson Investment Management Company Inc. purchased a new position in Amrize in the third quarter worth approximately $5,191,000. Norman Fields Gottscho Capital Management LLC increased its stake in Amrize by 24.8% during the third quarter. Norman Fields Gottscho Capital Management LLC now owns 10,155 shares of the company’s stock worth $493,000 after acquiring an additional 2,015 shares during the last quarter. Finally, Ipswich Investment Management Co. Inc. acquired a new position in shares of Amrize in the 3rd quarter valued at $4,091,000.

Amrize Trading Up 0.4%

Shares of NYSE:AMRZ opened at $55.85 on Thursday. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $56.76. The firm has a 50 day moving average price of $51.30. The stock has a market cap of $30.89 billion and a P/E ratio of 30.35. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.85 and a current ratio of 1.38.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company had revenue of $3.68 billion for the quarter, compared to analysts’ expectations of $3.49 billion. Amrize’s quarterly revenue was up 6.6% on a year-over-year basis.

Insiders Place Their Bets

In related news, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the acquisition, the director owned 4,958 shares in the company, valued at approximately $234,711.72. This represents a 67.61% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jaime Hill purchased 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 4th. The shares were bought at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the completion of the purchase, the insider directly owned 18,101 shares in the company, valued at $917,539.69. This represents a 28.37% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 65,000 shares of company stock worth $3,399,720 over the last 90 days.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Amrize to a “hold” rating in a report on Saturday, October 25th. Oppenheimer assumed coverage on Amrize in a research note on Tuesday, September 9th. They set an “outperform” rating and a $62.00 target price on the stock. Deutsche Bank Aktiengesellschaft set a $59.00 price objective on shares of Amrize in a report on Monday, December 8th. Vertical Research started coverage on shares of Amrize in a research note on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target for the company. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Amrize in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $60.00.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.